AlphaYouMB
Insider selling
Matthew B. Klein sold $706K of Ptc Therapeutics, Inc. (PTCT) stock
Matthew B. Klein, Chief Executive Officer of Ptc Therapeutics, Inc. (PTCT), sold 10,292 shares of PTCT stock worth $706K, per an SEC Form 4 filed Aug 6, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 4, 2026, 2 days before it was made public.
PTCT has moved -5.6% since the trade date, from $69.10 to $65.26 (Sep 21, 2026 close).
- Traded
- Aug 4, 2026
- Disclosed
- Aug 6, 2026
- Filing delay
- 2 days
- Price since
- -5.6%
- Role
- Chief Executive Officer
- Source
- SEC Form 4
More PTCT insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.